Evidence map›Paper›PMID 30513259›Full record

ArticlemAbs2019

C

Seiki Yageta, Hiroshi Imamura, Risa Shibuya, Shinya Honda

Open access · goldAbstract readComparative Study
In one paragraph

Article in mAbs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Glycan Remodeling Technologies for Enhancing Antibody Function.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Getting Smaller by Denaturation: Acid-Induced Compaction of Antibodies.The journal of physical chemistry letters · 2023
    Article
  4. Article
  5. Review
  6. The Contorsbody, an antibody format for agonism: Design, structure, and function.Computational and structural biotechnology journal · 2020
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Seiki Yagetaa Biomedical Research Institute , National Institute of Advanced Industrial Science and Technology (AIST) , Tsukuba, Ibaraki , Japan.
Hiroshi Imamuraa Biomedical Research Institute , National Institute of Advanced Industrial Science and Technology (AIST) , Tsukuba, Ibaraki , Japan.ORCID 0000-0001-8924-747X
Risa Shibuyab Department of Computational Biology and Medical Sciences , Graduate School of Frontier Sciences, the University of Tokyo , Kashiwa , Chiba , Japan.ORCID 0000-0002-1337-9334
Shinya Hondaa Biomedical Research Institute , National Institute of Advanced Industrial Science and Technology (AIST) , Tsukuba, Ibaraki , Japan.ORCID 0000-0002-7878-3944
National Institute of Advanced Industrial Science and Technology · JPRitsumeikan University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The N-linked glycan in immunoglobulin G is critical for the stability and function of the crystallizable fragment (Fc) region. Alteration of these protein properties upon the removal of the N-linked glycan has often been explained by the alteration of the C

Indexed as

HumansImmunoglobulin Fc FragmentsImmunoglobulin GProtein DomainsX-Ray DiffractionImmunoglobulin Fc FragmentsImmunoglobulin Gcrystallizable fragment regionImmunoglobulin G-linked glycansingular value decompositionsmall-angle X-ray scattering

Identifiers

PMID30513259
PMCPMC6512918
OpenAlexW2903065790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.